Research Paper Volume 15, Issue 9 pp 3715—3737
Plasmon-activated water as a therapeutic strategy in Alzheimer’s disease by altering gut microbiota
Figure 3. Radioactivity uptake assay of fecal microbiota transplantation (FMT) and plasmon-activated water (PAW)-fed AD mice. (A) 18F-Florbetapir animal positron emission tomographic (PET) images were generated from 16-month-old wild-type (WT), WT fed PAW and FMT WT, AD, PAW-fed AD, and FMT AD mice. The color bar of the right line shows the standardized uptake value ratio (SUVR) compared to the cerebellum (SUVRcer). (B) Comparison of relative 18F-florbetapir uptake levels in the cortex, striatum, and hippocampus of the brain. All results were analyzed by ANOVA with a post hoc analysis. (*p < 0.05, **p < 0.01, ***p < 0.001). Mean values ± standard deviation of mean (SD) was shown.